| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 106 |
| 1 | CYCLOPHOSPHAMIDE | 75 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 75 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 75 |
| 4 | BORTEZOMIB | 57 |
| 5 | AZATHIOPRINE | 56 |
| 6 | DOXORUBICIN | 55 |
| 7 | PREDNISOLONE | 52 |
| 8 | PREDNISOLONE ORAL | 52 |
| 9 | PREDNISOLONE ORAL SOLUTION | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AURANOFIN | 1 | 0.0049 |
| 1 | ETOPOSIDE PHOSPHATE | 7 | 0.0043 |
| 2 | PYRIMETHAMINE | 2 | 0.0016 |
| 3 | RALTEGRAVIR | 7 | 0.0013 |
| 4 | ROMIDEPSIN | 2 | 0.0012 |
| 5 | SIROLIMUS | 16 | 0.0012 |
| 6 | ETHAMBUTOL HYDROCHLORIDE | 3 | 0.0011 |
| 7 | RIFABUTIN | 3 | 0.0011 |
| 8 | PENICILLAMINE | 1 | 0.0011 |
| 9 | ADALIMUMAB-FKJP | 47 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 202 |
| 1 | Alkylating Drug [EPC] | 83 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 71 |
| 3 | Proteasome Inhibitor [EPC] | 62 |
| 4 | Purine Antimetabolite [EPC] | 56 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 35 |
| 7 | Aminosalicylate [EPC] | 33 |
| 8 | Topoisomerase Inhibitor [EPC] | 33 |
| 9 | Interleukin-12 Antagonist [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 2 | Rifamycin Antimycobacterial [EPC] | 3 | 0.0009 |
| 3 | Lipopeptide Antibacterial [EPC] | 7 | 0.0007 |
| 4 | Somatostatin Analog [EPC] | 5 | 0.0007 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Purine Antimetabolite [EPC] | 56 | 0.0006 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 12 | 0.0006 |
| 8 | Proteasome Inhibitor [EPC] | 62 | 0.0005 |
| 9 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |